Calcyphosine 抗体 (AA 101-189) (AbBy Fluor® 350)
Our Local Distributor
北京 101111
Quick Overview for Calcyphosine 抗体 (AA 101-189) (AbBy Fluor® 350) (ABIN1395513)
抗原
See all Calcyphosine (CAPS) 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 101-189
-
交叉反应
- 人
-
预测反应
- Dog,Cow,Sheep,Pig,Rabbit
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human Calcyphosine 1
-
亚型
- IgG
-
-
anti-Calcyphosine (CAPS) (AA 1-109) antibody
CAPS 适用: 人 WB, ELISA, RNAi 宿主: 小鼠 Monoclonal 4C6 unconjugated
anti-Calcyphosine (CAPS) (AA 1-189) antibodyCAPS 适用: 人 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Calcyphosine (CAPS) (AA 1-189) antibodyCAPS 适用: 人 WB, IHC (p) 宿主: 小鼠 Polyclonal unconjugated
anti-Calcyphosine (CAPS) (AA 1-189) antibodyCAPS 适用: 人 WB, IP 宿主: 兔 Polyclonal unconjugated
anti-Calcyphosine (CAPS) (AA 1-189) antibodyCAPS 适用: 人 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Calcyphosine (CAPS) (N-Term) antibodyCAPS 适用: 人, 猴 WB 宿主: 兔 Polyclonal unconjugated
anti-Calcyphosine (CAPS) (N-Term) antibodyCAPS 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Calcyphosine (CAPS) (N-Term) antibodyCAPS 适用: 人, 马, Pig, 兔, 大鼠 WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- Calcyphosine (CAPS)
-
别名
- Calcyphosine 1/CAPS1
-
背景
-
Synonyms: Calcyphosin, Calcyphosine 1, Calcyphosine, CAPS, CAPS1, CAYP1_HUMAN, Thyroid protein p24.
Background: CAPS1 is a 189 amino acid cytoplasmic protein that contains four EF-hand domains, which serve as calcium-binding sites, and was first identified in canine thyroid. Interestingly, CAPS1 is much less abundant in humans than in canines. Synthesis and phosphorylation of CAPS1 is upregulated by cAMP-agonists in thyrocytes. CAPS1 likely functions in the regulation of ionic transport and may be involved in cross-signaling between cAMP and Ca(+2)-phophatidylinositol cascades. In addition to thyriod, CAPS1 is expressed in brain, salivary glands and lung. Expression of CAPS1 is increased in endometrial cancer and prognosis seems to be dependent on the level of CAPS1 expression, indicating that CAPS1 may be an appropriate prognostic marker for patient survival.
抗原
-
